Header Logo

Roger G Harrison

TitleProfessor
InstitutionUniversity of Oklahoma, Norman
DepartmentChemical, Biological and Materials Engineering
Addressn/a
100 Boyd St
Norman OK 73019
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Faria GNF, Karch CG, Chakraborty S, Gu T, Woodward A, Aissanou A, Lageshetty S, Silvy RP, Resasco D, Ballon JA, Harrison RG. Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1. J Pharmacol Exp Ther. 2024 Jun 21; 390(1):65-77. PMID: 38772718.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Woodward A, Southard B, Chakraborty S, Bailey AO, Faria GNF, McKernan P, Razaq W, Harrison RG. Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Mol Biomed. 2024 Apr 02; 5(1):16. PMID: 38564119; PMCID: PMC10987452.
      Citations:    
    3. Woodward A, Southard B, Chakraborty S, Bailey AO, Faria GNF, McKernan P, Razaq W, Harrison RG. Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Mol Biomed. 2024 Feb 19; 5(1):7. PMID: 38369647; PMCID: PMC10874913.
      Citations:    Translation:Humans
    4. Yang W, Frickenstein AN, Sheth V, Holden A, Mettenbrink EM, Wang L, Woodward AA, Joo BS, Butterfield SK, Donahue ND, Green DE, Thomas AG, Harcourt T, Young H, Tang M, Malik ZA, Harrison RG, Mukherjee P, DeAngelis PL, Wilhelm S. Controlling Nanoparticle Uptake in Innate Immune Cells with Heparosan Polysaccharides. Nano Lett. 2022 09 14; 22(17):7119-7128. PMID: 36048773; PMCID: PMC9486251.
      Citations: 10     Fields:    
    5. Woodward A, Faria GNF, Harrison RG. Annexin A5 as a targeting agent for cancer treatment. Cancer Lett. 2022 10 28; 547:215857. PMID: 35940392.
      Citations: 11     Fields:    Translation:Humans
    6. McKernan P, Cassidy B, Woodward A, Battiste J, Drevets D, Harrison R. Corrigendum to "Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli" [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]. Int J Antimicrob Agents. 2021 Nov; 58(5):106423. PMID: 34518079.
      Citations:    Fields:    
    7. McKernan P, Virani NA, Faria GNF, Karch CG, Prada Silvy R, Resasco DE, Thompson LF, Harrison RG. Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer. Nanoscale Res Lett. 2021 Jan 07; 16(1):9. PMID: 33411055.
      Citations: 15     
    8. McKernan P, Cassidy B, Woodward A, Battiste J, Drevets D, Harrison R. Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli. Int J Antimicrob Agents. 2020 Dec; 56(6):106183. PMID: 33045345.
      Citations:    Fields:    Translation:HumansCells
    9. Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol. 2019 Sep; 14(9):902. PMID: 31358944.
      Citations:    Fields:    
    10. Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, Neves JD, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol. 2019 Aug; 14(8):811. PMID: 31289407.
      Citations: 3     Fields:    
    11. Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol. 2019 07; 14(7):629-635. PMID: 31270452.
      Citations: 57     Fields:    Translation:HumansAnimals
    12. Virani NA, Thavathiru E, McKernan P, Moore K, Benbrook DM, Harrison RG. Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer. Cancer Lett. 2018 07 01; 425:174-182. PMID: 29574275.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    13. Virani NA, Davis C, McKernan P, Hauser P, Hurst RE, Slaton J, Silvy RP, Resasco DE, Harrison RG. Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer. Nanotechnology. 2018 Jan 19; 29(3):035101. PMID: 29160225.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    14. Krais JJ, Virani N, McKernan PH, Nguyen Q, Fung KM, Sikavitsas VI, Kurkjian C, Harrison RG. Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Mol Cancer Ther. 2017 09; 16(9):1855-1865. PMID: 28522586.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    15. Guillen KP, Ruben EA, Virani N, Harrison RG. Annexin-directed ß-glucuronidase for the targeted treatment of solid tumors. Protein Eng Des Sel. 2017 Feb; 30(2):85-94. PMID: 27986920.
      Citations:    Fields:    Translation:HumansCells
    16. Guillen KP, Restuccia A, Kurkjian C, Harrison RG. Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer. Pancreas. 2015 Aug; 44(6):945-52. PMID: 25899647.
      Citations:    Fields:    Translation:HumansCells
    17. Harrison RG, Bagajewicz MJ. Predicting the solubility of recombinant proteins in Escherichia coli. Methods Mol Biol. 2015; 1258:403-8. PMID: 25447878.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    18. Guillen KP, Kurkjian C, Harrison RG. Targeted enzyme prodrug therapy for metastatic prostate cancer - a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase. J Biomed Sci. 2014 Jul 22; 21:65. PMID: 25047949.
      Citations: 8     Fields:    Translation:HumansCells
    19. Krais JJ, De Crescenzo O, Harrison RG. Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy. PLoS One. 2013; 8(10):e76403. PMID: 24098491.
      Citations: 7     Fields:    Translation:HumansCells
    20. Van Rite BD, Krais JJ, Cherry M, Sikavitsas VI, Kurkjian C, Harrison RG. Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature. Cancer Invest. 2013 Oct; 31(8):505-10. PMID: 24083814.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    21. Neves LF, Krais JJ, Van Rite BD, Ramesh R, Resasco DE, Harrison RG. Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. Nanotechnology. 2013 Sep 20; 24(37):375104. PMID: 23975064.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    22. Prickett WM, Van Rite BD, Resasco DE, Harrison RG. Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology. 2011 Nov 11; 22(45):455101. PMID: 21993223.
      Citations: 4     Fields:    Translation:HumansCells
    23. Van Rite BD, Harrison RG. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Lett. 2011 Aug 01; 307(1):53-61. PMID: 21546157.
      Citations: 8     Fields:    Translation:HumansCells
    24. Van Rite BD, Lazrak YA, Pagnon ML, Palwai NR, Neves LF, McFetridge PS, Harrison RG. Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature. Cancer Lett. 2011 Feb 28; 301(2):177-84. PMID: 21194833.
      Citations: 7     Fields:    Translation:HumansCells
    25. Diaz AA, Tomba E, Lennarson R, Richard R, Bagajewicz MJ, Harrison RG. Prediction of protein solubility in Escherichia coli using logistic regression. Biotechnol Bioeng. 2010 Feb 01; 105(2):374-83. PMID: 19739095.
      Citations: 26     Fields:    Translation:Cells
    26. Neves LF, Tsai TW, Palwai NR, Martyn DE, Tan Y, Schmidtke DW, Resasco DE, Harrison RG. Non-covalent attachment of proteins to single-walled carbon nanotubes. Methods Mol Biol. 2010; 625:3-8. PMID: 20422376.
      Citations:    Fields:    Translation:Cells
    27. Tsai TW, Heckert G, Neves LF, Tan Y, Kao DY, Harrison RG, Resasco DE, Schmidtke DW. Adsorption of glucose oxidase onto single-walled carbon nanotubes and its application in layer-by-layer biosensors. Anal Chem. 2009 Oct 01; 81(19):7917-25. PMID: 19788314.
      Citations: 12     Fields:    Translation:Cells
    28. Palwai NR, Zang XP, Harrison RG, Benbrook D, Pento JT. Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor. Pharmacology. 2009; 84(5):271-5. PMID: 19797936.
      Citations: 1     Fields:    Translation:HumansCells
    29. Palwai NR, Zang XP, Harrison RG, Pento JT. Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells. Anticancer Res. 2007 Sep-Oct; 27(5A):3435-9. PMID: 17970092.
      Citations:    Fields:    Translation:HumansCells
    30. Zang XP, Palwai NR, Lerner MR, Brackett DJ, Pento JT, Harrison RG. Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration. Anticancer Res. 2006 May-Jun; 26(3A):1745-51. PMID: 16827102.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    31. Huang X, Ding WQ, Vaught JL, Wolf RF, Morrissey JH, Harrison RG, Lind SE. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood. 2006 Feb 01; 107(3):980-6. PMID: 16195337.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    32. Peron K, Jones TN, Gauthier SA, Nguyen TN, Zang XP, Barriere M, Prévéraud D, Soliman CE, Harrison RG, Pento JT. Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation. Cancer Chemother Pharmacol. 2003 Oct; 52(4):270-6. PMID: 12827296.
      Citations: 1     Fields:    Translation:HumansCells
    33. Davis GD, Harrison RG. Discovery of new fusion protein systems designed to enhance solubility in E. coli. Methods Mol Biol. 2003; 205:141-54. PMID: 12491884.
      Citations: 1     Fields:    Translation:Cells
    34. Harrison RG. Purification of recombinant proteins from yeast. Bioprocess Technol. 1991; 12:183-91. PMID: 1367084.
      Citations:    Fields:    Translation:Animals
    Harrison's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (180)
    Explore
    _
    Co-Authors (17)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _